pubmed· e01.org

PubMed · PMID 28759727

The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.

PMID 28759727Journal Canadian journal of physiology and pharmacologyYear 2017Authors 11DOI 10.1139/cjpp-2016-0561

  • Source PubMed
  • Journal Canadian journal of physiology and pharmacology
  • Year 2017
  • Authors Magdalena Izdebska; Iwona Piątkowska-Chmiel; Agnieszka Korolczuk; Mariola Herbet; Monika Gawrońska-Grzywacz; Renata Gieroba; Marcin Sysa; Klaudia Czajkowska-Bania; Marcelina Cygal; Agnieszka Korga; Jarosław Dudka
  • Licence NLM/PubMed terms

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently one of the most common chronic liver diseases, especially in developed countries. One group of substances with a potential use in the treatment of NAFLD are plant polyphenols, represented by resveratrol. The aim of this study was to evaluate the effect of resveratrol on steatosis and oxidative stress in HepG2 cells. The steatosis of cells was carried out using free fatty acids: oleic or palmitic acid and their mixtures.

Steatosis was visualized using the intracellular lipid staining by Nile Red dye with a fluorescence microscope. This study also determined the viability of cells and mitochondrial membrane potential. The current study showed that fatty acids and their mixtures induced fat overloading in HepG2 cells. In the group of cells incubated with oleic acid (OA), observed changes were moderate with prevailing micro-vesicular steatosis.

In case of cells incubated with palmitic acid (PA) and the mixtures of fatty acids, micro- and macro-vacuolar steatosis occurred in most of the cells. Resveratrol decreased steatosis in HepG2 cells induced by OA, PA, as well as their mixtures, and in most of experimental groups did not reduce cells viability. Resveratrol reduced the oxidative stress in HepG2 cells treated with fatty acids mixtures.

Record details

PMID28759727
PMCIDnot held
DOI10.1139/cjpp-2016-0561
JournalCanadian journal of physiology and pharmacology
Year2017
AuthorsMagdalena Izdebska; Iwona Piątkowska-Chmiel; Agnieszka Korolczuk; Mariola Herbet; Monika Gawrońska-Grzywacz; Renata Gieroba; Marcin Sysa; Klaudia Czajkowska-Bania; Marcelina Cygal; Agnieszka Korga; Jarosław Dudka
Licencenot stated
MeSHCell Survival; Cytoprotection; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Mitochondria; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Palmitic Acid; Resveratrol; Stilbenes

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
28759727
Rendered
2026-11-21
Completeness
abstract and citation fields